Courier Health Raises $50M Series B to Build AI-Powered Patient…

Team S · 2026-04-22T15:02:27.000Z

US-based healthtech startup Courier Health has raised $50 million in a Series B funding round to expand its AI-powered patient experience platform built for the biopharmaceutical industry, as life sciences companies increasingly prioritize personalized engagement and treatment access support. The round was led by Oak HC/FT, with participation from existing investors and strategic backers, signaling strong confidence in digital infrastructure that helps pharma brands improve patient journeys across complex therapies and specialty care. Founded to modernize how biopharma companies connect with patients, Courier Health provides CRM and patient relationship management software tailored for life sciences organizations. Its platform enables manufacturers to manage onboarding, adherence, support programs, and ongoing communication in a more consumer-grade, data-driven manner. Traditional patient support programs in pharma often rely on fragmented vendors, outdated systems, and disconnected data sources. Courier Health aims to replace this model with a unified platform that helps brands streamline enrollment, improve therapy starts, reduce abandonment, and strengthen long-term patient outcomes. A major focus of the new funding will be expansion of the company’s AI capabilities. These tools are expected to automate workflows, personalize outreach, surface insights for care teams, and improve efficiency across support operations reflecting the broader rise of AI in healthcare engagement. The company plans to use the new capital to scale product development, grow commercial teams, and deepen partnerships with biopharma clients launching specialty medicines in areas such as oncology, rare disease, and immunology. As drug innovation advances rapidly, the patient experience layer has become increasingly important. Courier Health is positioning itself as a next-generation infrastructure provider at the intersection of healthcare, software, and AI helping biopharma companies translate scientific breakthroughs into better real-world access and outcomes

Member Login Get Access

Courier Health Raises $50M Series B to Build AI-Powered Patient… | Newnex